{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T01:23:51Z","timestamp":1778289831726,"version":"3.51.4"},"reference-count":15,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2006,5,1]],"date-time":"2006-05-01T00:00:00Z","timestamp":1146441600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2006,5]]},"DOI":"10.1016\/j.clinthera.2006.05.015","type":"journal-article","created":{"date-parts":[[2006,7,25]],"date-time":"2006-07-25T07:57:04Z","timestamp":1153814224000},"page":"707-714","source":"Crossref","is-referenced-by-count":37,"title":["Pharmacokinetic properties of fentanyl effervescent buccal tablets: A phase I, open-label, crossover study of single-dose 100, 200, 400, and 800 \u03bcg in healthy adult volunteers"],"prefix":"10.1016","volume":"28","author":[{"given":"Mona","family":"Darwish","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary","family":"Kirby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr.","given":"Philmore","family":"Robertson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Tracewell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John G.","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl 5","key":"10.1016\/j.clinthera.2006.05.015_bib1","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.1016\/j.jpainsymman.2005.01.009","article-title":"Fentanyl","volume":"29","author":"Stanley","year":"2005","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.clinthera.2006.05.015_bib2","first-page":"354","article-title":"Consensus panel recommendations for the assessment and management of breakthrough pain: Pam 2: Management","volume":"30","author":"Bennett","year":"2005","journal-title":"Pharm Ther."},{"key":"10.1016\/j.clinthera.2006.05.015_bib3","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.jpainsymman.2005.04.014","article-title":"Alternative treatments of breakthrough pain in patients receiving spinal analgesics for cancer pain","volume":"30","author":"Mercadante","year":"2005","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.clinthera.2006.05.015_bib4","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0304-3959(00)00427-9","article-title":"Break through cancer pain: A randomized trial comparing oral transmucosal fentanyl citrate (OTFC) and morphine sulfate immediate release (MSIR)","volume":"91","author":"Coluzzi","year":"2001","journal-title":"Pain"},{"issue":"Suppl 3","key":"10.1016\/j.clinthera.2006.05.015_bib5","doi-asserted-by":"crossref","first-page":"S40","DOI":"10.1016\/0885-3924(92)90052-J","article-title":"Transdermal fentanyl: Suggested recommendations for clinical use","volume":"7","author":"Payne","year":"1992","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.clinthera.2006.05.015_bib6_1","first-page":"215","article-title":"Alternatives to oral opioids for cancerpain","volume":"13","author":"Mercadante","year":"1999","journal-title":"Oncology (Willismn Park)"},{"key":"10.1016\/j.clinthera.2006.05.015_bib6_2","first-page":"225","article-title":"Alternatives to oral opioids for cancerpain","volume":"13","author":"Mercadante","year":"1999","journal-title":"Oncology (Willismn Park)"},{"key":"10.1016\/j.clinthera.2006.05.015_bib7","doi-asserted-by":"crossref","first-page":"304","DOI":"10.12968\/ijpn.2002.8.6.10501","article-title":"The role of oral transmucosal fentanyl citrate in the management of breakthrough cancer pain","volume":"8","author":"Rees","year":"2002","journal-title":"Int J Palliat Nurs"},{"key":"10.1016\/j.clinthera.2006.05.015_bib8","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1191\/026921601678320304","article-title":"Sublingual fentanylcitrate for cancer-related breakthrough pain: A pilot study","volume":"15","author":"Zeppetella","year":"2001","journal-title":"Palliat Med"},{"key":"10.1016\/j.clinthera.2006.05.015_bib9","series-title":"International Conference on Harmonisation-World Health Organization","author":"European Agency for the Evaluation of Medicinal Products","year":"2002"},{"key":"10.1016\/j.clinthera.2006.05.015_bib10","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.2165\/00003088-200544120-00006","article-title":"Pharmacokinetics and dose proportionality of Fentanyl effervescent buccal tablets in healthy volunteers","volume":"44","author":"Darwish","year":"2005","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.clinthera.2006.05.015_bib11","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1023\/A:1026451721686","article-title":"Confidence interval criteria forassessment ofdose proportionality","volume":"17","author":"Smith","year":"2000","journal-title":"Pharm Res"},{"key":"10.1016\/j.clinthera.2006.05.015_bib12","doi-asserted-by":"crossref","first-page":"P76","DOI":"10.1016\/j.clpt.2004.12.181","article-title":"Pharmacokinetics, safety and tolerability of a novel 100 \u03bcg\/h transdermal fentanyl patch co-administered with 100 mg oral naltrexone in healthy males","volume":"77","author":"For","year":"2005","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.clinthera.2006.05.015_bib13","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/00000542-198110000-00006","article-title":"Tissue redistribution offentanyl and termination of its effects in rats","volume":"55","author":"Hug","year":"1981","journal-title":"Anestnesiology"},{"key":"10.1016\/j.clinthera.2006.05.015_bib14","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1097\/00000542-198603000-00006","article-title":"Pharmacokinetics offentanyl in patients undergoing abdominal aortic surgery","volume":"64","author":"Hudson","year":"1986","journal-title":"Anesthesiology"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291806001263?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291806001263?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,14]],"date-time":"2019-01-14T17:22:02Z","timestamp":1547486522000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291806001263"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,5]]},"references-count":15,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2006,5]]}},"alternative-id":["S0149291806001263"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2006.05.015","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2006,5]]}}}